Mangoceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Mangoceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8083% to $731,493. Profit margin reached -1259%. Total operating expenses were $9,650,391.
Profit Margin
| 2021 | 0 | -17.70K | |
|---|---|---|---|
| 2022 | 8.93K | -1.99M | -22352.11% |
| 2023 | 731.49K | -9.21M | -1259.4% |
MGRX Income Statement (2021 – 2023)
| 2023 | 2022 | 2021 | |
|---|---|---|---|
Revenue | |||
Revenue | 731.49K | 8.93K | 0 |
Cost of revenue | 299.99K | 4.08K | 0 |
Gross profit | 431.50K | 4.85K | 0 |
Operating exp. | |||
Research and development | 0 | 0 | 0 |
Selling and marketing | 2.09M | 352.86K | -52.56K |
Total operating expenses | 9.65M | 1.99M | 17.52K |
Operating income | -9.21M | -1.99M | -17.52K |
Other income (expenses), net | 6.47K | -6.47K | -181 |
Income before tax | -9.21M | -1.99M | -17.70K |
Income tax expense | 0 | 0 | -70.08K |
Net income | -9.21M | -1.99M | -17.70K |
Earnings per share | |||
Basic EPS | -6.45 | -0.12 | -0.00 |
Diluted EPS | -6.45 | -0.12 | -0.00 |
| Data source |